Related Experiment Video
Updated: Mar 26, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic
Christina Doesch1, Dirk Lossnitzer1, Boris Rudic1
11. 1st Department of Medicine Cardiology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany ; 2. DZHK (German Centre for Cardiovascular Research) partner site Mannheim, Germany.
Insights
Atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients is linked to specific cardiac magnetic resonance (CMR) findings. Reduced right ventricular function and right atrial enlargement predict AF occurrence in HCM.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Hypertrophic Cardiomyopathy Research
Background:
- Atrial fibrillation (AF) is a significant complication in hypertrophic cardiomyopathy (HCM), leading to adverse clinical outcomes.
- Identifying predictors of AF in HCM is crucial for risk stratification and management.
Purpose of the Study:
- To evaluate cardiac magnetic resonance (CMR)-derived determinants for the occurrence of AF in patients with HCM.
- To identify imaging biomarkers for predicting AF development in HCM patients.
Main Methods:
- A cohort of 98 patients with HCM and 30 healthy controls underwent CMR.
- Patients were followed for approximately 6 years to monitor AF occurrence.
- CMR parameters including left ventricular mass, atrial volumes, and annular plane systolic excursion were assessed.
Main Results:
- 19.4% of HCM patients had AF at diagnosis, and another 19.4% developed AF during follow-up.
- HCM patients with AF showed reduced tricuspid annular plane systolic excursion (TAPSE) and right atrial (RA) dilatation compared to those in sinus rhythm (SR).
- TAPSE, RA diameter, and septal mitral annular plane systolic excursion (MAPSE) demonstrated good predictive performance for AF risk.
Conclusions:
- Reduced TAPSE and RA dilatation are potential imaging markers for AF in HCM patients.
- Enlarged left atrial (LA) volumes and reduced septal MAPSE are common in HCM but less specific for AF prediction.
- These easily determinable CMR markers can aid in identifying HCM patients at risk for AF.
Objectives And Background:
Atrial fibrillation (AF) is associated with clinical deterioration, stroke and disability in patients with hypertrophic cardiomyopathy (HCM). Therefore, the objective of this study was to evaluated cardiac magnetic resonance (CMR)-derived determinants for the occurrence of AF in patients with HCM.
Methods:
98 Patients with HCM and 30 healthy controls underwent CMR and were followed-up for 6 ± 3 years.
Results:
19 (19.4%) patients presented with AF at initial diagnosis, 19 (19.4%) developed AF during follow-up and 60 (61.2%) remained in sinus rhythm (SR). Compared to healthy controls, patients with HCM who remained in SR presented with significantly increased left ventricular mass, an elevated left ventricular remodeling index, enlarged left atrial volumes and reduced septal mitral annular plane systolic excursion (MAPSE) compared to healthy controls. Whereas HCM patients who presented with AF at initial diagnosis and those who developed AF during follow-up additionally presented with reduced tricuspid annular plane systolic excursion (TAPSE) and right atrial (RA) dilatation. Receiver-operator curve analysis indicated good predictive performance of TAPSE, RA diameter and septal MAPSE (AUC 0.73, 0.69 and 0.71, respectively) to detect patients at risk of developing AF.
Conclusion:
Reduced MAPSE measurements and enlarged LA volumes seems to be a common feature in patients with HCM, whereas reduced TAPSE and RA dilatation only seem to be altered in patients with history of AF and those developing AF. Therefore, they could serve as easy determinable markers of AF in patients with HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

